NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 2nd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.50 per share on Monday, February 3rd. This represents a $2.00 annualized dividend and a yield of 2.63%. The ex-dividend date is Wednesday, January 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings results on Wednesday, November, 6th. The pharmacy operator reported $1.84 EPS for the quarter, topping analysts' consensus estimates of $1.77 by $0.07. The pharmacy operator had revenue of $64.81 billion for the quarter, compared to the consensus estimate of $62.99 billion. CVS Health had a return on equity of 15.45% and a net margin of 1.83%. The firm's revenue for the quarter was up 36.5% compared to the same quarter last year. During the same period last year, the firm posted $1.73 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus estimate of $6.98.

24 equities research analysts have issued twelve-month price targets for CVS Health's shares. Their forecasts range from $61.00 to $97.00. On average, they anticipate CVS Health's stock price to reach $77.43 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price. View Analyst Price Targets for CVS Health.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 6 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News coverage about CVS stock has trended positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of 2.9 on InfoTrie's scale. They also gave press coverage about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Verizon Communications (VZ), Johnson & Johnson (JNJ), Bank of America (BAC) and AbbVie (ABBV).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.09%), Artemis Investment Management LLP (0.06%), Country Trust Bank (0.05%), Gateway Investment Advisers LLC (0.05%), Birch Hill Investment Advisors LLC (0.05%) and Cacti Asset Management LLC (0.04%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Rhenman & Partners Asset Management AB, Commerzbank Aktiengesellschaft FI, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Hexavest Inc., Ellis Investment Partners LLC, Clean Yield Group and UNIVEST FINANCIAL Corp. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Artemis Investment Management LLP, Johanson Financial Advisors Inc., Corbenic Partners LLC, F&V Capital Management LLC, Sanders Morris Harris LLC, Country Trust Bank and Manning & Napier Group LLC. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $76.02.

CVS Health has a market capitalization of $98.90 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]